Serial

The first aim of the OncomiRs journal is to become the central publication venue for all members of the researcher community working on microRNAs biology and cancer research. It will centralize the novelties of this exciting new research field and will become the missing place to share information about the implication of microRNAs in oncology.

Submitting to OncomiRs will give you a unique chance to highlight your research work in the only specialized microRNA and cancer research journal. Moreover, thanks to its Open Access model of publication, manuscripts accepted for publication are immediately published on-line.

It will give you the opportunity to present your work and get advises from the prominent scholars of its Advisory Board.

Among other advantages to submit your work to OncomiRs, you can note:

• Every author receives fast, fair and constructive peer-review
• Efficient route to fast-track publication
• Free English language assistance provided for authors of accepted articles
• Extensive promotion of every published article to hundreds of researchers working in the same field
• Modern publishing service and high-quality electronic publication technologies

OncomiRs is an international, peer-reviewed, open-access journal that welcomes original research relevant to the interdisciplinary nature of microRNAs and cancer biology. For readers, the journal aims to become an authoritative and central publication venue and will facilitate the sharing and dissemination of significant contributions and timely research in the emerging field of microRNAs in cancer. The journal will publish original research articles and reviews covering all the basics aspects of the microRNAs implication in tumor formation and development as well as their role in the treatment sensitivity and resistance. The OncomiRs journal will focus on the basic principles of microRNAs implication in the regulation of cellular processes like apoptosis, cell cycle control, metastatic dissemination, cellular senescence and immortalisation. A particular attention will be given to microRNA-controled regulation of cellular oncogenes and tumor suppressor genes.

• Journal Editor: Benjamin Ory, Nantes University School of Medicine, France

• Editors

Journal Editor

Benjamin Ory

bory@versita.com

Editorial Office

Versita Ltd.

ul. Solipska 14a/1

02-482 Warsaw, Poland

Phone: +48 22 701 50 15